| Ident. | Authors (with country if any) | Title |
|---|
| 000032 |
N. Daviaud [France] ; E. Garbayo [France, Espagne] ; N. Lautram [France] ; F. Franconi [France] ; L. Lemaire [France] ; M. Perez-Pinzon [États-Unis] ; C. N. Montero-Menei [France] | MODELING NIGROSTRIATAL DEGENERATION IN ORGANOTYPIC CULTURES, A NEW EX VIVO MODEL OF PARKINSON'S DISEASE |
| 000068 |
F. Bourdain [France] ; M. Tir [France] ; J.-M. Trocello [France] | Les syndromes parkinsoniens: de l'analyse sémiologique au diagnostic nosologique |
| 000081 |
E. Broussolle [France] ; J.-M. Trocello [France] ; F. Woimant [France] ; A. Lachaux [France] ; N. Quinn [Royaume-Uni] | Samuel Alexander Kinnier Wilson. Wilson's disease, Queen Square and neurology : Maladie de Wilson |
| 000088 |
Jan T Nnesen [Suède, France] | Optogenetic cell control in experimental models of neurological disorders |
| 000090 |
C. Duyckaerts [France] | Neurodegenerative lesions: Seeding and spreading |
| 000292 |
Varduhi H. Knaryan [États-Unis] ; Supriti Samantaray [États-Unis] ; Charlene Le Gal [France] ; Swapan K. Ray [États-Unis] ; Naren L. Banik [États-Unis] | Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies |
| 000295 |
Timothy P. Gilmour [États-Unis] ; Christopher A. Lieu [États-Unis] ; Mark J. Nolt [États-Unis] ; Brigitte Piallat [France] ; Milind Deogaonkar [États-Unis] ; Thyagarajan Subramanian [États-Unis] | The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys |
| 000359 |
Masahiro Shin [France] ; Caroline Jan [France] ; Carine Jacquard [France] ; Bechir Jarraya [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Stephane Palfi [France] ; Emmanuel Brouillet [France] | Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration |
| 000375 |
F. Tison [France] | « Drapeaux rouges »: quand s'alarmer, quel examens demander ? |
| 000401 |
M.-L. Welter [France] ; G. W. M. Westby [France] ; N. Chastan [France] | Les troubles de la marche et de l'équilibre dans les syndromes parkinsoniens « plus » : Troubles de la marche |
| 000535 |
N. Le Forestier [France] ; L. Lacomblez [France] ; V. Meininger [France] | Syndromes parkinsoniens et sclérose latérale amyotrophique Tauopathies, TDP-43 et mutations SOD |
| 000612 |
Vincent Henry [France] ; Vincent Paille [France] ; Faustine Lelan [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Kinetics of Microglial Activation and Degeneration of Dopamine-Containing Neurons in a Rat Model of Parkinson Disease Induced by 6-Hydroxydopamine |
| 000619 |
Anne-Sophie Rolland [France] ; Dominique Tande [France] ; Maria-Trinidad Herrero [Espagne] ; Maria-Rosario Luquin [Espagne] ; Marianne Vazquez-Claverie [Espagne] ; Carine Karachi [France] ; Etienne C. Hirsch [France] ; Chantal Francois [France] | Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication |
| 000736 |
Luca Ferraro [Italie] ; Maria Cristina Tomasini [Italie] ; Roberta Mazza [Italie] ; Kjell Fuxe [Suède] ; Jacqueline Fournier [France] ; Sergio Tanganelli [Italie] ; Tiziana Antonelli [Italie] | Neurotensin receptors as modulators of glutamatergic transmission |
| 000797 |
Stéphanie Pain [France] ; Laurence Barrier [France] ; Julie Deguil [France] ; Serge Milin [France] ; Alain Piriou [France] ; Bernard Fauconneau [France] ; Guylène Page [France] | A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats |
| 000836 |
A. Echaniz-Laguna [France] ; L. Dupuis [France] | Anomalies mitochondriales dans la sclérose latérale amyotrophique : cause ou conséquence ? |
| 000856 |
Dieter Scheller [Allemagne] ; PIU CHAN [République populaire de Chine] ; QIN LI [Royaume-Uni] ; TAO WU [République populaire de Chine] ; RENLING ZHANG [République populaire de Chine] ; LE GUAN [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Celine Guigoni [France] ; Alan R. Crossman [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France] | Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease |
| 000867 |
Duong P. Huynh [États-Unis] ; Dung T. Nguyen [États-Unis] ; Johannes B. Pulst-Korenberg [États-Unis] ; Alexis Brice [France] ; Stefan-M. Pulst [États-Unis] | Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death |
| 000876 |
S. Rivaud-Pechoux [France] ; M. Vidailhet [France] ; J. P. Brandel [France] ; B. Gaymard [France] | Mixing pro-and antisaccades in patients with parkinsonian syndromes |
| 000967 |
Canan Ozsancak [France] ; P. Auzou [France] ; M. Jan [France] ; L. Defebvre [France] ; Ph. Derambure [France] ; A. Destee [France] | The place of perceptual analysis of dysarthria in the differential diagnosis of corticobasal degeneration and Parkinson's disease |
| 000A06 |
Valentina Vasina [Italie] ; Giovanni Barbara [Italie] ; Luigia Talamonti [Italie] ; Vincenzo Stanghellini [Italie] ; Roberto Corinaldesi [Italie] ; Marcello Tonini [Italie] ; Fabrizio De Ponti [Italie] ; Roberto De Giorgio [Italie] | Enteric neuroplasticity evoked by inflammation |
| 000A23 |
A.-M. Shiarli [Royaume-Uni] ; R. Jennings [Royaume-Uni] ; J. Shi [Royaume-Uni, République populaire de Chine] ; K. Bailey [Royaume-Uni] ; Y. Davidson [Royaume-Uni] ; J. Tian [Royaume-Uni, République populaire de Chine] ; E. H. Bigio [États-Unis] ; B. Ghetti [États-Unis] ; J. R. Murrell [États-Unis] ; M. B. Delisle [France] ; S. Mirra [États-Unis] ; B. Crain [États-Unis] ; P. Zolo [Italie] ; K. Arima [Japon] ; E. Iseki [Japon] ; S. Murayama [Japon] ; H. Kretzschmar ; M. Neumann ; C. Lippa ; G. Halliday ; J. Mackenzie ; N. Khan ; R. Ravid ; D. Dickson ; Z. Wszolek ; T. Iwatsubo ; S. M. Pickering-Brown [Royaume-Uni] ; D. M. A. Mann [Royaume-Uni] | Comparison of extent of tau pathology in patients with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease |
| 000A58 |
I. Ghorayeb [France] ; E. Bezard [France] ; P. O. Fernagut [France] ; B. Bioulac [France] ; F. Tison [France] | Modèles animaux des syndromes parkinsoniens |
| 000B00 |
Magali Periquet [France] ; Olga Corti [France] ; Sandrine Jacquier [France] ; Alexis Brice [France] | Proteomic analysis of parkin knockout mice : alterations in energy metabolism, protein handling and synaptic function |
| 000B41 |
Alexandre Kreisler [France] ; Luc Defebvre [France] ; Pascal Lecouffe [France] ; Alain Duhamel [France] ; Pierre Charpentier [France] ; Marc Steinling [France] ; Alain Destée [France] | Corticobasal degeneration and Parkinson's disease assessed by HmPaO spect : The utility of factorial discriminant analysis |
| 000C22 |
Canan Ozsancak [France] ; Pascal Auzou [France] ; Kathy Dujardin [France] ; Niall Quinn [Royaume-Uni] ; Alain Destée [France] | Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease |
| 000C29 |
P. O. Fernagut [France] ; E. Diguet [France] ; B. Bioulac [France] ; F. Tison [France] | MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: eeference to striatonigral degeneration |
| 000C46 |
Carlos Barcia [Espagne] ; Angel Sanchez Bahillo [Espagne] ; Emiliano Fernandez-Villalba [Espagne] ; Victor Bautista [Espagne] ; Maximo Poza Y. Poza [Espagne] ; Andrés Fernandez-Barreiro [Espagne] ; Etienne C. Hirsch [France] ; Maria-Trinidad Herrero [Espagne] | Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure |
| 000C56 |
N. A. Do Thi [France] ; P. Saillour [France] ; L. Ferrero [France] ; I. F. Dedieu [France] ; J. Mallet [France] ; T. Paunio [France, Finlande] | Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease |
| 000C92 |
A. Destee [France] | Neuroprotection et syndromes parkinsoniens neurodégénératifs |
| 000C93 |
L. Defebvre [France] ; F. Cassim [France] | Neurophysiologie des syndromes parkinsoniens |
| 000D19 |
F. Tison [France] | Critères diagnostiques des syndromes parkinsoniens |
| 000D20 |
Ch. Pierrot-Deseilligny [France] ; S. Rivaud-Pechoux [France] | Contribution de l'examen de l'oculomotricité au diagnostic étiologique des syndromes parkinsoniens |
| 000D48 |
Erwan Bezard [France] ; Christian E. Gross [France] ; Jonathan M. Brotchie [Canada] | Presymptomatic compensation in Parkinson's disease is not dopamine-mediated |
| 000D58 |
Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease |
| 000E00 |
Günter U. Höglinger [France, Allemagne] ; Jean Feger [France] ; Annick Prigent [France] ; Patrick P. Michel [France] ; Karine Parain [France] ; Pierre Champy [France] ; Merle Ruberg [France] ; Wolfgang H. Oertel [Allemagne] ; Etienne C. Hirsch [France] | Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats |
| 000E94 |
T. Debeir [France] ; M. Marien [France] ; P. Chopin [France] ; J.-C. Martel [France] ; F. Colpaert [France] ; R. Raisman-Vozari [France] | Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat |
| 000F44 |
Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France] | Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice |
| 000F46 |
I. Ghorayeb [France] ; P. O. Fernagut [France] ; N. Stefanova [Autriche] ; G. K. Wenning [Autriche] ; B. Bioulac [France] ; F. Tison [France] | Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine + 3-nitropropionic acid model of striatonigral degeneration in monkeys |
| 001043 |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
| 001084 |
S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France] | Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease |
| 001134 |
C. Duyckaerts [France] ; J. Takahashi [France] ; J. Hogenhuis [France] ; J.-J. Hauw [France] | Les démences dégénératives à l'exclusion de la maladie d'Alzheimer |
| 001192 |
Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse] | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease |
| 001198 |
N. W. Kowall [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] ; A. C. Mckee [États-Unis] ; R. J. Ferrante [États-Unis] | MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons |
| 001232 |
C. Scherfler [Autriche] ; Z. Puschban [Autriche] ; I. Ghorayeb [France] ; G. P. Goebel [Autriche] ; F. Tison [France] ; K. Jellinger [Autriche] ; Werner Poewe [Autriche] ; G. K. Wenning [Autriche] | Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy) |
| 001266 |
L. Defebvre [France] ; HABERT ; SAMSON ; VIDAILHET ; TOUCHON ; SCHROEDER ; BAULAC ; BAULIEU | Pathologie extrapyramidale. Apport de l'imagerie de perfusion et du métabolisme (TEP, TEM). Discussion |
| 001281 |
M. Vidailhet [France] | Diagnostic clinique des syndromes parkinsoniens |
| 001354 |
I. Litvan [États-Unis] ; D. A. Grimes [Canada] ; A. E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; A. Mckee [États-Unis] ; M. Verny [France] ; K. Jellinger [Autriche] ; K. R. Chaudhuri [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] | Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration |
| 001358 |
B. A. Faucheux [France] ; A.-M. Bonnet [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Blood vessels change in the mesencephalon of patients with Parkinson's disease |
| 001378 |
| Canaux K+ et neurodégénérescence : implication des canaux K+ sensibles à l'ATP et des canaux K+ régulés par les protéines G dans la dégénérescence neuronale |
| 001402 |
A. Nieoullon [France] | Bases cellulaires des processus neurodégénératifs |
| 001470 |
| Toxicité du glutamate sur des cultures primaires de neurones mésencéphaliques de la substance noire |
| 001542 |
A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France] | Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects |
| 001553 |
P. P. Michel [France] ; M. Ruberg [France] ; Yves Agid [France] | Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside |
| 001569 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Kinetics of nigral degeneration in a chronic model of MPTP-treated mice |
| 001581 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. Gross [France] | Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice |
| 001598 |
I. Litvan [États-Unis] ; Yves Agid [France] ; C. Goetz [États-Unis] ; Joseph Jankovic [États-Unis] ; G. K. Wenning [Royaume-Uni] ; J. P. Brandel [France] ; E. C. Lai [États-Unis] ; M. Verny [France] ; K. Ray-Chaudhuri [Royaume-Uni] ; A. Mckee [États-Unis] ; K. Jellinger [Autriche] ; R. K. B. Pearce [Royaume-Uni] ; J. J. Bartko [États-Unis] | Accuracy of the clinical diagnosis of corticobasal degeneration : A clinicopathologic study |
| 001665 |
L. Taupenot [France] ; J. Ciesielski-Treska [France] ; G. Ulrich [France] ; S. Chasserot-Golaz [France] ; D. Aunis [France] ; M.-F. Bader [France] | Chromogranin a triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells |
| 001674 |
| Analyse moléculaire et cellulaire de la mutation weaver de la souris |
| 001690 |
Yves Agid [France] ; L. Montagnier ; M. Bourel ; G. Serratrice ; R. Nordmann ; G. Blancher ; C. Pilet ; M.-O. Mme Rethore ; H. Lestradet ; J. Polonovski ; H. Bouissou ; P. Lefebvre ; J.-L. De Gennes | Le vieillissement, la maladie et la mort des cellules nerveuses. Discussion |
| 001695 |
C. Chatellard-Causse [France] ; C. Feuerstein | La dégénérescence des neurones catécholaminergiques |
| 001714 |
R.-M. Marie ; L. Barre [France] ; P. Rioux ; P. Allain [France] ; B. Lechevalier ; J.-C. Baron | PET imaging of neocortical monoaminergic terminals in Parkinson's disease |
| 001716 |
B. Pillon [France] ; N. Gouider-Khouja ; B. Deweer ; M. Vidailhet ; C. Malapani ; B. Dubois ; Yves Agid [France] | Neuropsychological pattern of striatonigral degeneration : comparison with Parkinson's disease and progressive supranuclear palsy |
| 001722 |
V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France] | Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain |
| 001746 |
N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France] | "Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study |
| 001805 |
A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch | Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease ? |
| 001810 |
P. Hantraye [France] ; E. Brouillet | Chronic treatment with mitochondrial toxins in primates as experimental models of Parkinson's and Huntington's diseases |
| 001830 |
Yves Agid [France] | Mécanisme de la mort cellulaire dans les affections neurodégénératives : à propos de la maladie de Parkinson |
| 001861 |
P. Hantraye [France] ; M. Varastet [France] ; M. Peschanski [France] ; D. Riche [France] ; P. Cesaro ; J. C. Willer ; M. Maziere [France] | Stable Parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons |
| 001947 |
P. P. Michel [France] ; Yves Agid [France] | The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures |
| 001954 |
A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
| 001A59 |
B. Dubois ; B. Pillon ; F. Lhermitte ; Yves Agid [France] | Cholinergic deficiency and frontal dysfunction in Parkinson's disease |
| 001A61 |
S. Malessa ; E. C. Hirsch ; P. Cervera ; C. Duyckaerts ; Yves Agid [France] | Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes : a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration |
| 001A64 |
J. Hugon [France] ; J. M. Vallat | Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid |
| 001A93 |
D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France] | Striatal dopamine deficiency in Parkinson's disease: role of aging |
| 001B26 |
E. Hirsch ; A. M. Graybiel ; Y. A. Agid | Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease |
| 001B82 |
B. Scatton ; T. Dennis ; R. L'Heureux ; J.-C. Monfort ; C. Duyckaerts ; F. Javoy-Agid | Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients |
